Technical Analysis for NRSNW - NeuroSense Therapeutics Ltd. - warrant
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Narrow Range Bar | Range Contraction | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Stochastic Buy Signal | Bullish | 5.66% | |
Narrow Range Bar | Range Contraction | 5.66% | |
Wide Bands | Range Expansion | 5.66% | |
Down 3 Days in a Row | Weakness | 5.66% | |
Down 4 Days in a Row | Weakness | 5.66% | |
Gapped Down | Weakness | 5.66% |
Alert | Time |
---|---|
1.5x Volume Pace | 1 day ago |
Up 5% | 1 day ago |
Up 3% | 1 day ago |
Up 2% | 1 day ago |
Up 1% | 1 day ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/01/2022
NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases in the United States and internationally. Its lead product is PrimeC, an extended-release oral formulation of a fixed dose combination of ciprofloxacin and celecoxib for the treatment of amyotrophic lateral sclerosis. The company's preclinical pipeline includes StabiliC for the treatment of Parkinson's disease; and CogniC for the treatment of Alzheimer's disease. NeuroSense Therapeutics Ltd. was incorporated in 2017 and is headquartered in Herzliya, Israel.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Alzheimer's Disease Parkinson's Disease Neurodegenerative Diseases Amyotrophic Lateral Sclerosis Treatment Of Parkinson's Disease Senescence Treatment Of Alzheimer's Disease Neurodegenerative Disease Clinical Neuroscience
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Alzheimer's Disease Parkinson's Disease Neurodegenerative Diseases Amyotrophic Lateral Sclerosis Treatment Of Parkinson's Disease Senescence Treatment Of Alzheimer's Disease Neurodegenerative Disease Clinical Neuroscience
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 0.64 |
52 Week Low | 0.073 |
Average Volume | 11,030 |
200-Day Moving Average | 0.23 |
50-Day Moving Average | 0.29 |
20-Day Moving Average | 0.26 |
10-Day Moving Average | 0.19 |
Average True Range | 0.05 |
RSI (14) | 36.71 |
ADX | 24.7 |
+DI | 17.10 |
-DI | 32.85 |
Chandelier Exit (Long, 3 ATRs) | 0.39 |
Chandelier Exit (Short, 3 ATRs) | 0.29 |
Upper Bollinger Bands | 0.43 |
Lower Bollinger Band | 0.09 |
Percent B (%b) | 0.15 |
BandWidth | 132.14 |
MACD Line | -0.05 |
MACD Signal Line | -0.03 |
MACD Histogram | -0.0159 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.14 | ||||
Resistance 3 (R3) | 0.14 | 0.14 | 0.14 | ||
Resistance 2 (R2) | 0.14 | 0.14 | 0.14 | 0.14 | |
Resistance 1 (R1) | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 |
Pivot Point | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 |
Support 1 (S1) | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 |
Support 2 (S2) | 0.14 | 0.14 | 0.14 | 0.14 | |
Support 3 (S3) | 0.14 | 0.14 | 0.14 | ||
Support 4 (S4) | 0.14 |